title: Infliximab and human immunodeficiency virus infection: Viral load reduction and CD4+ T-cell loss related to apoptosis.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Filippi
authors.forename: Pierre-Marie
authors.initials: PM
authors.lastname: Roger
authors.forename: Stéphane M
authors.initials: SM
authors.lastname: Schneider
authors.forename: Jacques
authors.initials: J
authors.lastname: Durant
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Breittmayer
authors.forename: Sylvia
authors.initials: S
authors.lastname: Benzaken
authors.forename: Alain
authors.initials: A
authors.lastname: Bernard
authors.forename: Pierre
authors.initials: P
authors.lastname: Dellamonica
authors.forename: Xavier
authors.initials: X
authors.lastname: Hébuterne
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D017209:Apoptosis / Q000187:drug effects*; D051940:B7-2 Antigen / Q000378:metabolism; D018791:CD4 Lymphocyte Count; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects; D003424:Crohn Disease / Q000188:drug therapy / Q000276:immunology; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D000069285:Infliximab; D019562:Viral Load
chemical_list: D000911:Antibodies, Monoclonal; D051940:B7-2 Antigen; D005765:Gastrointestinal Agents; D000069285:Infliximab